Patents by Inventor Michele Resche Rigon

Michele Resche Rigon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ZP3 FRAGMENTS IN IMMUNOTHERAPY OF OVARIAN CANCER
    Publication number: 20210317165
    Abstract: The invention relates to zona pellucida protein (ZP3) fragments, and their use in immunotherapy of ovarian cancer.
    Type: Application
    Filed: September 2, 2019
    Publication date: October 14, 2021
    Inventors: Michèle RESCHE-RIGON, Charlotte DUVAL, Eric TARTOUR, Marie ANSON
  • Ulipristal acetate for prevention and treatment of breast tumors
    Patent number: 9814732
    Abstract: The invention relates to the use of ulipristal acetate, or any of its metabolites, in preventing or treating a breast tumor in a patient, preferably a patient that carries a mutation in BRCA1 gene.
    Type: Grant
    Filed: July 29, 2016
    Date of Patent: November 14, 2017
    Assignees: Laboratoire HRA-PHARMA, INSERM (Institut National de la Sante et de la Recherche Medicale)
    Inventors: Michele Resche-Rigon, Delphine Levy, Erin Gainer, Anne Gompel, Patricia Forgez, Laudine Desreumaux-Communal
  • ULIPRISTAL ACETATE FOR PREVENTION AND TREATMENT OF BREAST TUMORS
    Publication number: 20170014426
    Abstract: The invention relates to the use of ulipristal acetate, or any of its metabolites, in preventing or treating a breast tumor in a patient, preferably a patient that carries a mutation in BRCA1 gene.
    Type: Application
    Filed: July 29, 2016
    Publication date: January 19, 2017
    Inventors: Michele RESCHE-RIGON, Delphine LEVY, Erin GAINER, Anne GOMPEL, Patricia FORGEZ, Laudine DESREUMAUX-COMMUNAL
  • COMBINATION OF SELECTIVE PROGESTERONE-RECEPTOR MODULATORS AND NONSTEROIDAL ANTI-INFLAMMATORY DRUGS
    Publication number: 20150150888
    Abstract: The invention relates to a pharmaceutical composition combining a selective progesterone receptor modulator (SPRM), such as ulipristal acetate, and one or more non-steroidal anti-inflammatory compounds, in particular in a method of regular contraception, or in emergency or on-demand contraception.
    Type: Application
    Filed: February 28, 2013
    Publication date: June 4, 2015
    Inventors: Michele Resche-Rigon, Delphine Levy, Erin Gainer
  • ULIPRISTAL ACETATE FOR PREVENTION AND TREATMENT OF BREAST TUMORS
    Publication number: 20150133418
    Abstract: The invention relates to the use of ulipristal acetate, or any of its metabolites, in preventing or treating a breast tumor in a patient, preferably a patient that carries a mutation in BRCA1 gene.
    Type: Application
    Filed: May 24, 2013
    Publication date: May 14, 2015
    Inventors: Michele Resche-Rigon, Delphine Levy, Erin Gainer, Anne Gompel, Patricia Forgez, Laudine Desreumaux-Communal
  • Steroids, their use as medicaments, their preparation process, the intermediates of this process and the compositions containing them
    Patent number: 6492536
    Abstract: The subject of the invention is the products of formula (I): in which either R1 represents halogen, hydroxyl, (C1-C8) alkyloxy or (C1-C12) acyloxy, and R2 represents halogen or hydrogen, or R1 and R2 form together a double bond, Z is chosen from optionally substituted (C1-C8) alkylthio, optionally substituted arylthio, (C1-C8) alkyloxy, halogen, cyano, mercapto, thiocyanato and (CH2)0-1—CO2H, optionally esterified, Y represents hydrogen or methyl, the dotted line in position 1-2 or 5-6 optionally representing a second bond, as well as their addition salts, their preparation process, the intermediates of this process and the pharmaceutical compositions containing them.
    Type: Grant
    Filed: June 25, 2001
    Date of Patent: December 10, 2002
    Assignee: Aventis Pharma S.A.
    Inventors: Neerja Bhatnagar, Andre Claussner, Christian Marchandeau, Michele Resche Rigon, Jean-Georges Teutsch
  • Steroids, their use as medicaments, their preparation process, the intermediates of this process and the compositions containing them
    Publication number: 20020002155
    Abstract: The subject of the invention is the products of formula (I): 1
    Type: Application
    Filed: June 25, 2001
    Publication date: January 3, 2002
    Applicant: Hoechst Marion Roussel
    Inventors: Neerja Bhatnagar, Andre Claussner, Christian Marchandeau, Michele Resche Rigon, Jean-Georges Teutsch
  • Pregnane derivatives with no alpha-17 substitutent, their medicinal use, manufacturing method and its intermediaries and related compounds
    Patent number: 6274572
    Abstract: The subject of the invention is the products of formula (I): in which either R1 represents halogen, hydroxyl, (C1-C8) alkyloxy or (C1-C12) acyloxy, and R2 represents halogen or hydrogen, or R1 and R2 form together a double bond, Z is chosen from optionally substituted (C1-C8) alkylthio, optionally substituted arylthio, (C1-C8) alkyloxy, halogen, cyano, mercapto, thiocyanato and (CH2)0-1—CO2H, optionally esterified, Y represents hydrogen or methyl, the dotted line in position 1-2 or 5-6 optionally representing a second bond, as well as their addition salts, their preparation process, the intermediates of this process and the pharmaceutical compositions containing them.
    Type: Grant
    Filed: December 21, 1998
    Date of Patent: August 14, 2001
    Assignee: Aventis Pharma S.A.
    Inventors: Neerja Bhatnagar, Andre Claussner, Christian Marchandeau, Michele Resche Rigon, Jean-Georges Teutsch